173 related articles for article (PubMed ID: 20156665)
1. Inhibition of necrotic actions of nitrogen-containing bisphosphonates (NBPs) and their elimination from bone by etidronate (a non-NBP): a proposal for possible utilization of etidronate as a substitution drug for NBPs.
Oizumi T; Funayama H; Yamaguchi K; Yokoyama M; Takahashi H; Yamamoto M; Kuroishi T; Kumamoto H; Sasaki K; Kawamura H; Sugawara S; Endo Y
J Oral Maxillofac Surg; 2010 May; 68(5):1043-54. PubMed ID: 20156665
[TBL] [Abstract][Full Text] [Related]
2. Necrotic actions of nitrogen-containing bisphosphonates and their inhibition by clodronate, a non-nitrogen-containing bisphosphonate in mice: potential for utilization of clodronate as a combination drug with a nitrogen-containing bisphosphonate.
Oizumi T; Yamaguchi K; Funayama H; Kuroishi T; Kawamura H; Sugawara S; Endo Y
Basic Clin Pharmacol Toxicol; 2009 May; 104(5):384-92. PubMed ID: 19413658
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxicity of zoledronate (nitrogen-containing bisphosphonate: NBP) and/or etidronate (non-NBP) in tumour cells and periodontal cells.
Tanaka Y; Nagai Y; Dohdoh M; Oizumi T; Ohki A; Kuroishi T; Sugawara S; Endo Y
Arch Oral Biol; 2013 Jun; 58(6):628-37. PubMed ID: 23245859
[TBL] [Abstract][Full Text] [Related]
4. Analgesic effects of the non-nitrogen-containing bisphosphonates etidronate and clodronate, independent of anti-resorptive effects on bone.
Kim S; Seiryu M; Okada S; Kuroishi T; Takano-Yamamoto T; Sugawara S; Endo Y
Eur J Pharmacol; 2013 Jan; 699(1-3):14-22. PubMed ID: 23201069
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphate transporters ameliorates the inflammatory and necrotic side effects of the nitrogen-containing bisphosphonate zoledronate in mice.
Okada S; Kiyama T; Sato E; Tanaka Y; Oizumi T; Kuroishi T; Takahashi T; Sasaki K; Sugawara S; Endo Y
Tohoku J Exp Med; 2013 Oct; 231(2):145-58. PubMed ID: 24140868
[TBL] [Abstract][Full Text] [Related]
6. Phosphonocarboxylates Can Protect Mice against the Inflammatory and Necrotic Side Effects of Nitrogen-Containing Bisphosphonates by Inhibiting Their Entry into Cells via Phosphate Transporters.
Kiyama T; Tsuchiya M; Okada S; Oizumi T; Yamaguchi K; Sasaki K; Sugawara S; Endo Y
Biol Pharm Bull; 2016; 39(5):712-20. PubMed ID: 27150143
[TBL] [Abstract][Full Text] [Related]
7. Osteonecrosis of the jawbones in 2 osteoporosis patients treated with nitrogen-containing bisphosphonates: osteonecrosis reduction replacing NBP with non-NBP (etidronate) and rationale.
Yamaguchi K; Oizumi T; Funayama H; Kawamura H; Sugawara S; Endo Y
J Oral Maxillofac Surg; 2010 Apr; 68(4):889-97. PubMed ID: 20056305
[No Abstract] [Full Text] [Related]
8. Release of Nitrogen-Containing Bisphosphonates (NBPs) from Hydroxyapatite by Non-NBPs and by Pyrophosphate.
Bando K; Oizumi T; Takahashi T; Mizoguchi I; Sugawara S; Endo Y
Biol Pharm Bull; 2021; 44(11):1670-1680. PubMed ID: 34719644
[TBL] [Abstract][Full Text] [Related]
9. Histidine decarboxylase-stimulating and inflammatory effects of alendronate in mice: involvement of mevalonate pathway, TNFalpha, macrophages, and T-cells.
Deng X; Yu Z; Funayama H; Yamaguchi K; Sasano T; Sugawara S; Endo Y
Int Immunopharmacol; 2007 Feb; 7(2):152-61. PubMed ID: 17178381
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of inflammatory and bone-resorption-inhibitory effects of alendronate by etidronate.
Funayama H; Ohsako M; Monma Y; Mayanagi H; Sugawara S; Endo Y
Calcif Tissue Int; 2005 Jun; 76(6):448-57. PubMed ID: 15895282
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory and necrotic effects of minodronate, a nitrogen-containing bisphosphonate, in mice.
Kiyama T; Okada S; Tanaka Y; Kim S; Bando K; Hasegawa M; Yamaguchi K; Takano-Yamamoto T; Sasaki K; Sugawara S; Endo Y
Tohoku J Exp Med; 2013 Jul; 230(3):141-9. PubMed ID: 23822921
[TBL] [Abstract][Full Text] [Related]
12. [Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates].
Endo Y; Funayama H; Yamaguchi K; Monma Y; Yu Z; Deng X; Oizumi T; Shikama Y; Tanaka Y; Okada S; Kim S; Kiyama T; Bando K; Shima K; Suzuki H; Takahashi T
Yakugaku Zasshi; 2020; 140(1):63-79. PubMed ID: 31902887
[TBL] [Abstract][Full Text] [Related]
13. Comparative appraisal of clodronate, aspirin and dexamethasone as agents reducing alendronate-induced inflammation in a murine model.
Yu Z; Funayama H; Deng X; Kuroishi T; Sasano T; Sugawara S; Endo Y
Basic Clin Pharmacol Toxicol; 2005 Oct; 97(4):222-9. PubMed ID: 16176557
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
Iwata K; Li J; Follet H; Phipps RJ; Burr DB
Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
[TBL] [Abstract][Full Text] [Related]
15. The effects of topical application of bisphosphonates on replanted rat molars.
Choi SC; Kwon YD; Kim KC; Kim GT
Dent Traumatol; 2010 Dec; 26(6):476-80. PubMed ID: 21078072
[TBL] [Abstract][Full Text] [Related]
16. Effects of bisphosphonates on joint damage and bone loss in rat adjuvant-induced arthritis.
Harada H; Nakayama T; Nanaka T; Katsumata T
Inflamm Res; 2004 Feb; 53(2):45-52. PubMed ID: 15021968
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of zoledronate and etidronate in osseous healing of an extracted socket and tibia defect.
Lim SS; Lee B; Kim IS; Hwang SJ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Jan; 123(1):8-19. PubMed ID: 27727104
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates.
Kimmel DB
J Dent Res; 2007 Nov; 86(11):1022-33. PubMed ID: 17959891
[TBL] [Abstract][Full Text] [Related]
19. Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates.
van Beek ER; Cohen LH; Leroy IM; Ebetino FH; Löwik CW; Papapoulos SE
Bone; 2003 Nov; 33(5):805-11. PubMed ID: 14623056
[TBL] [Abstract][Full Text] [Related]
20. The Bisphosphonates Clodronate and Etidronate Exert Analgesic Effects by Acting on Glutamate- and/or ATP-Related Pain Transmission Pathways.
Shima K; Nemoto W; Tsuchiya M; Tan-No K; Takano-Yamamoto T; Sugawara S; Endo Y
Biol Pharm Bull; 2016; 39(5):770-7. PubMed ID: 27150146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
